Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
44.49
+0.45 (1.02%)
At close: Nov 7, 2025, 4:00 PM EST
45.47
+0.98 (2.20%)
After-hours: Nov 7, 2025, 7:46 PM EST
Hinge Health Stock Forecast
Stock Price Forecast
The 14 analysts that cover Hinge Health stock have a consensus rating of "Strong Buy" and an average price target of $60.07, which forecasts a 35.02% increase in the stock price over the next year. The lowest target is $45 and the highest is $71.
Price Target: $60.07 (+35.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hinge Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 |
| Buy | 8 | 9 | 9 | 9 | 9 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $61 → $65 | Strong Buy | Maintains | $61 → $65 | +46.10% | Nov 5, 2025 |
| Barclays | Barclays | Buy Maintains $62 → $65 | Buy | Maintains | $62 → $65 | +46.10% | Nov 5, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $70 → $71 | Buy | Reiterates | $70 → $71 | +59.59% | Nov 5, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +46.10% | Oct 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $57 → $67 | Buy | Maintains | $57 → $67 | +50.60% | Sep 23, 2025 |
Financial Forecast
Revenue This Year
561.52M
from 390.40M
Increased by 43.83%
Revenue Next Year
672.09M
from 561.52M
Increased by 19.69%
EPS This Year
0.59
from -0.88
EPS Next Year
1.17
from 0.59
Increased by 96.45%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 582.9M | 731.9M | |||
| Avg | 561.5M | 672.1M | |||
| Low | 537.9M | 630.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 49.3% | 30.3% | |||
| Avg | 43.8% | 19.7% | |||
| Low | 37.8% | 12.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.64 | 1.46 | |||
| Avg | 0.59 | 1.17 | |||
| Low | -6.36 | 0.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 145.3% | |||
| Avg | - | 96.4% | |||
| Low | - | 18.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.